Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial. (nature.com)

Authors: Ogbogu PU … Klion AD Journal: Nature Medicine Published: 2026-06-01 DOI: https://doi.org/10.1038/s41591-026-04315-8